BACKGROUND AND PURPOSE: Hyperthermia treatment planning (HTP) is used in the head and neck region (H&N) for pretreatment optimization, decision making, and real-time HTP-guided adaptive application of hyperthermia. In current clinical practice, HTP is based on power-absorption predictions, but thermal dose-effect relationships advocate its extension to temperature predictions. Exploitation of temperature simulations requires region- and temperature-specific thermal tissue properties due to the strong thermoregulatory response of H&N tissues. The purpose of our work was to develop a technique for patient group-specific optimization of thermal tissue properties based on invasively measured temperatures, and to evaluate the accuracy achievable. PATIENTS AND METHODS: Data from 17 treated patients were used to optimize the perfusion and thermal conductivity values for the Pennes bioheat equation-based thermal model. A leave-one-out approach was applied to accurately assess the difference between measured and simulated temperature (∆T). The improvement in ∆T for optimized thermal property values was assessed by comparison with the ∆T for values from the literature, i.e., baseline and under thermal stress. RESULTS: The optimized perfusion and conductivity values of tumor, muscle, and fat led to an improvement in simulation accuracy (∆T: 2.1 ± 1.2 °C) compared with the accuracy for baseline (∆T: 12.7 ± 11.1 °C) or thermal stress (∆T: 4.4 ± 3.5 °C) property values. CONCLUSION: The presented technique leads to patient group-specific temperature property values that effectively improve simulation accuracy for the challenging H&N region, thereby making simulations an elegant addition to invasive measurements. The rigorous leave-one-out assessment indicates that improvements in accuracy are required to rely only on temperature-based HTP in the clinic.
BACKGROUND AND PURPOSE:Hyperthermia treatment planning (HTP) is used in the head and neck region (H&N) for pretreatment optimization, decision making, and real-time HTP-guided adaptive application of hyperthermia. In current clinical practice, HTP is based on power-absorption predictions, but thermal dose-effect relationships advocate its extension to temperature predictions. Exploitation of temperature simulations requires region- and temperature-specific thermal tissue properties due to the strong thermoregulatory response of H&N tissues. The purpose of our work was to develop a technique for patient group-specific optimization of thermal tissue properties based on invasively measured temperatures, and to evaluate the accuracy achievable. PATIENTS AND METHODS: Data from 17 treated patients were used to optimize the perfusion and thermal conductivity values for the Pennes bioheat equation-based thermal model. A leave-one-out approach was applied to accurately assess the difference between measured and simulated temperature (∆T). The improvement in ∆T for optimized thermal property values was assessed by comparison with the ∆T for values from the literature, i.e., baseline and under thermal stress. RESULTS: The optimized perfusion and conductivity values of tumor, muscle, and fat led to an improvement in simulation accuracy (∆T: 2.1 ± 1.2 °C) compared with the accuracy for baseline (∆T: 12.7 ± 11.1 °C) or thermal stress (∆T: 4.4 ± 3.5 °C) property values. CONCLUSION: The presented technique leads to patient group-specific temperature property values that effectively improve simulation accuracy for the challenging H&N region, thereby making simulations an elegant addition to invasive measurements. The rigorous leave-one-out assessment indicates that improvements in accuracy are required to rely only on temperature-based HTP in the clinic.
Authors: René F Verhaart; Valerio Fortunati; Gerda M Verduijn; Theo van Walsum; Jifke F Veenland; Margarethus M Paulides Journal: Radiother Oncol Date: 2014-03-13 Impact factor: 6.280
Authors: M M Paulides; J F Bakker; M Linthorst; J van der Zee; Z Rijnen; E Neufeld; P M T Pattynama; P P Jansen; P C Levendag; G C van Rhoon Journal: Phys Med Biol Date: 2010-04-06 Impact factor: 3.609
Authors: Marianne Linthorst; Tomas Drizdal; Hans Joosten; Gerard C van Rhoon; Jacoba van der Zee Journal: Strahlenther Onkol Date: 2011-11-25 Impact factor: 3.621
Authors: Geetha Sreenivasa; Johanna Gellermann; Beate Rau; Jacek Nadobny; Peter Schlag; Peter Deuflhard; Roland Felix; Peter Wust Journal: Int J Radiat Oncol Biol Phys Date: 2003-02-01 Impact factor: 7.038
Authors: J Hartmann; J Gellermann; T Brandt; M Schmidt; S Pyatykh; J Hesser; O Ott; R Fietkau; C Bert Journal: Technol Cancer Res Treat Date: 2016-07-14
Authors: Gerben Schooneveldt; Hana Dobšíček Trefná; Mikael Persson; Theo M de Reijke; Klas Blomgren; H Petra Kok; Hans Crezee Journal: Cancers (Basel) Date: 2019-08-15 Impact factor: 6.639
Authors: Iva VilasBoas-Ribeiro; Sven A N Nouwens; Sergio Curto; Bram de Jager; Martine Franckena; Gerard C van Rhoon; W P M H Heemels; Margarethus M Paulides Journal: Med Phys Date: 2022-06-26 Impact factor: 4.506